![Yakov Kogan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yakov Kogan
Directeur Général chez
Panacela Labs, Inc.
Profil
Yakov Kogan was the founder of Cleveland BioLabs, Inc. (founded in 2003, titles: Chief Executive & Financial Officer, Secretary) and Statera Biopharma, Inc. (founded in 2003, title: Senior Vice President-Strategy & Alliance).
Current jobs include Chief Executive Officer at Panacela Labs, Inc. (since 2011), Director & Principal Business Officer at Kadvax Technologies, Inc. (job end: null), and Chief Operations Officer at Genome Protection, Inc. (job end: null).
Former jobs include Director-Business Development at Integrated Genomics, Inc. (2002-2003), Director at Incuron LLC, Director at Quad M Solutions, Inc. (2022), Senior Scientist at ThermoGen, Inc., and Research Associate at The University of Chicago.
Education includes an MBA from The University of Chicago, a graduate degree from Moscow State University Lomonosov, and a doctorate from VNII Ekonomiki Selskogo Khozaystva.
Postes actifs de Yakov Kogan
| Sociétés | Poste | Début |
|---|---|---|
Panacela Labs, Inc.
 Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs against cancer | Directeur Général | - |
Kadvax Technologies, Inc.
 Kadvax Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research services | Directeur/Membre du Conseil | - |
Genome Protection, Inc.
 Genome Protection, Inc. Miscellaneous Commercial ServicesCommercial Services Genome Protection, Inc. is a clinical-stage biopharmaceutical company focused on developing medical interventions to prevent and treat aging and age-related diseases. The company is based in Buffalo, NY. The company’s technologies are based on insights into mechanisms leading to genomic instability, impairment of immunity, and systemic inflammation in aging. Genome Protection develops drugs, including TLR5 agonists entolimod and GP532, that are projected to improve immune functions in the elderly. The company also applies its research and development capabilities to create a pipeline of small-molecule and immunotherapeutic drug candidates targeting mechanisms underlying genomic instability in somatic tissues during aging and cancer progression, driven by endogenous retroelements. | Directeur des opérations | - |
Anciens postes connus de Yakov Kogan
| Sociétés | Poste | Fin |
|---|---|---|
| STATERA BIOPHARMA, INC. | Directeur Général | 13/12/2019 |
Integrated Genomics, Inc.
 Integrated Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides bioinformatics products to support research in microbial genomics, biochemistry and gene expression | Corporate Officer/Principal | 01/01/2003 |
| QUAD M SOLUTIONS, INC. | Directeur des opérations | - |
| STATERA BIOPHARMA, INC. | Fondateur | - |
Incuron LLC
 Incuron LLC Pharmaceuticals: MajorHealth Technology Develops anticancer drugs | Directeur/Membre du Conseil | - |
Formation de Yakov Kogan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
50
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Quad M Solutions, Inc.
 Quad M Solutions, Inc. Personnel ServicesCommercial Services Operates as a holding company whose subsidiaries provides staffing and business consulting services | Commercial Services |
Cleveland BioLabs, Inc.
 Cleveland BioLabs, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to activate the immune system and address serious medical needs | Health Technology |
Panacela Labs, Inc.
Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs against cancer | Health Technology |
Integrated Genomics, Inc.
Integrated Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides bioinformatics products to support research in microbial genomics, biochemistry and gene expression | Commercial Services |
ThermoGen, Inc.
 ThermoGen, Inc. Medical SpecialtiesHealth Technology Develops biocatalysts for pharmaceutical production | Health Technology |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Moscow State University Lomonosov
 Moscow State University Lomonosov Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Incuron LLC
Incuron LLC Pharmaceuticals: MajorHealth Technology Develops anticancer drugs | Health Technology |
VNII Ekonomiki Selskogo Khozaystva
 VNII Ekonomiki Selskogo Khozaystva Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kadvax Technologies, Inc.
Kadvax Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research services | Commercial Services |
Genome Protection, Inc.
Genome Protection, Inc. Miscellaneous Commercial ServicesCommercial Services Genome Protection, Inc. is a clinical-stage biopharmaceutical company focused on developing medical interventions to prevent and treat aging and age-related diseases. The company is based in Buffalo, NY. The company’s technologies are based on insights into mechanisms leading to genomic instability, impairment of immunity, and systemic inflammation in aging. Genome Protection develops drugs, including TLR5 agonists entolimod and GP532, that are projected to improve immune functions in the elderly. The company also applies its research and development capabilities to create a pipeline of small-molecule and immunotherapeutic drug candidates targeting mechanisms underlying genomic instability in somatic tissues during aging and cancer progression, driven by endogenous retroelements. | Commercial Services |
Statera Biopharma, Inc.
 Statera Biopharma, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops novel small molecule immunotherapies | Health Technology |
